Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bayer CropScience's share price for the quarter that ended in Mar. 2026 was ₹4651.6. Bayer CropScience's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 45 Mil. Therefore, Bayer CropScience's market cap for the quarter that ended in Mar. 2026 was ₹209,052 Mil.
Bayer CropScience's quarterly market cap
declined
from Sep. 2025 (₹216,050 Mil) to Dec. 2025 (₹204,967 Mil) but then
increased
from Dec. 2025 (₹204,967 Mil) to Mar. 2026 (₹209,052 Mil).
Bayer CropScience's annual market cap
declined
from Mar. 2024 (₹235,633 Mil) to Mar. 2025 (₹221,445 Mil) and
declined
from Mar. 2025 (₹221,445 Mil) to Mar. 2026 (₹209,052 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bayer CropScience's Enterprise Value for Today is ₹171,593 Mil.
Bayer CropScience (BOM:506285) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bayer CropScience Market Cap Related Terms
Bayer CropScience Market Cap Historical Data
* Premium members only.
The historical data trend for Bayer CropScience's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:506285 vs CTVA, CF, MOS: Market Cap Comparison
For the Agricultural Inputs subindustry, Bayer CropScience's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayer CropScience Market Cap vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Bayer CropScience's Market Cap distribution charts can be found below:
* The bar in red indicates where Bayer CropScience's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bayer CropScience's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bayer CropScience (BOM:506285) has a Market Cap of ₹185,689 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bayer CropScience and its competitors. According to the industry distribution chart, Bayer CropScience ranks #32 out of 264 companies in the Agriculture industry, placing it in the top 12.1%.
Is Bayer CropScience's Market Cap too high?
Bayer CropScience's current Market Cap is ₹185,689 Mil. Based on the distribution chart, Bayer CropScience ranks #32 out of 264 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Bayer CropScience has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bayer CropScience's Market Cap compare to CTVA and CF?
According to the Agriculture industry distribution chart, Bayer CropScience ranks #32 out of 264 companies for Market Cap. This places Bayer CropScience in the top 12% of its industry — outperforming the majority of peers. The industry median Market Cap is 203.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for an Agriculture company?
The median Market Cap among Agriculture companies is 203.80, based on 264 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bayer CropScience and its competitors. For the Agriculture industry, the median Market Cap is 203.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayer CropScience's current Market Cap is ₹185,689 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer CropScience stock overvalued right now?
Based on GuruFocus' analysis, Bayer CropScience (BOM:506285) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹5,902.44, compared to a current price of ₹4,131.75 — trading 30% below its estimated fair value. The current Market Cap is ₹185,689 Mil. Bayer CropScience's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bayer CropScience (BOM:506285), the current Market Cap is ₹185,689 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bayer CropScience (BOM:506285) Overvalued in 2026?
Based on GuruFocus' analysis, Bayer CropScience stock appears to be undervalued.
The current stock price of ₹4,131.75 is trading 30% below its estimated GF Value™ of ₹5,902.44.
GuruFocus considers Bayer CropScience to be Significantly Undervalued.
Key valuation signals for BOM:506285:
Market Cap: ₹185,689 Mil
GF Value™: ₹5,902.44 vs. price of ₹4,131.75 (30% below fair value)
No single metric tells the full story. See the BOM:506285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bayer CropScience Ltd manufactures, distributes, and sells crop protection and hybrid seed products to the agriculture industry. The firm sells fungicides, weedicides, hybrid seeds, consumer in-home pest-control products, and other agrochemical products. Its geographical segments are India, Germany, Bangladesh, and others, of which the vast majority of its revenue comes from India. The company is a subsidiary of Bayer AG, with the majority of common shares owned by its parent company and other Bayer AG subsidiaries.
87GF Score
Get the complete analysis for BOM:506285
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506285 has been successfully added to your 
